RESOLUTION OF HEPATORENAL SYNDROME IN A 50-YEAR-OLD MALE WITH TERLIPRESSIN THERAPY: A CASE REPORT
Main Article Content
Keywords
Hepatorenal syndrome, Terlipressin, Cirrhosis, Acute kidney injury, Terlipressin
Abstract
Background
Hepatorenal Syndrome (HRS) is a severe and potentially reversible renal dysfunction seen in patients with advanced liver disease. Prompt diagnosis and treatment are essential to prevent progression and improve survival.
Case Presentation
We present the case of a 50-year-old male with decompensated cirrhosis who developed Type 1 HRS. The patient was treated with intravenous albumin and terlipressin. Significant clinical and biochemical improvement was noted within one week of therapy.
Conclusion
Early identification and initiation of terlipressin therapy can lead to complete resolution of
HRS, potentially reducing the need for dialysis and bridging patients to liver transplantation.
References
2. Boyer TD, et al. Terlipressin plus albumin improves renal function in hepatorenal syndrome. Gastroenterology2008.
3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of decompensated cirrhosis. J Hepatol. 2018.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Nalla Varun Reddy
Pg Resentment of General Medicine, KM Medical College and Hospital
Dr Manish Mahlawat
Pg Resident, Dept of General Medicine, KM Medical College and Hospital
Dr. Trishool Surya
Pg Resident, Dept of General Medicine, KM Medical College and Hospital
Dr RP Gupta
Professor & Head of Department, Dept of General Medicine